Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry, announces it will launch two medical cannabis applications for the global medical cannabis market.
In early July 2017, GCAC will launch Citizen Green’s CannaMed and CannaLife, two apps built specifically for new and existing global medical cannabis users that will be available in German, English, Italian, French and Spanish across the globe.  Both applications utilize GCAC’s CannaCube Pain To Strain™ user-friendly technology that incorporates a proprietary database of over 10 years of field research that uniquely allows medicinal cannabis users to create individual user profile preferences to address one or multiple conditions for which they seek therapeutic benefits
Built from the original Citizen Green app code base, CannaMed users worldwide can learn more about the medical cannabis products they are using and read other users’ feedback as well as provide their own.
The highly customizable user profile assists CannaMed users in discovering other options that have helped patients with the same condition.  By turning on or off certain product attributes, CannaMed users can view a wide array of product options and reviews to personalize their experience even more.  Where cannabis is legally sold in dispensaries, online or pharmacies, CannaMed displays the best product options on an interactive map.
GCAC’s CannaLife is the first medicinal cannabis-related social media platform of its kind.  Similar to CannaMed, users create a unique user profile using CannaCube, allowing them to create unique profile preferences.  Using the information from these preferences, CannaLife users have access to multiple options based on topics of interest.  Using a dedicated cannabis-specific in-app search engine, CannaLife users can create and post content, join or create related topic-based communities, tag topics across multiple platforms, share information and receive and send alerts.  Both CannaLife and CannaMed are both joined by a single sign on process, similar to leading apps like Facebook and Instagram, allowing user community bases to easily share and grow.
The Company’s business is focused on big data, aggregated through mobile technology that enables patients, doctors, pharmacists, providers and practitioners to more easily identify key strains of cannabis that have the most benefit to target ailments and foster personal well being.  Unique to GCAC is the integration of user-generated data aggregated over 10 years of observational reports for pain relief / benefits, matched to a derived strain of cannabis or plant extract.
States CEO Brad Moore, “Unlike other online marijuana resources  that have been purely recreational, all Citizen Green apps are truly about medical cannabis.  We are using an innovative approach of technology and user rich data to help our app users learn, understand and participate in the growing world of medical cannabis.”
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative mobile applications.  Used in over 25 countries, GCAC’s apps facilitate the proliferation of digital conversations by like-minded people.  Managed by digital industry experts, GCAC is focused on viral global expansion by providing the best user experience in each target market.  Its leading mobile platforms are Citizen Green, a family of apps dedicated to the digital world of all things cannabis; Foro, a peer-to-peer mobile ecommerce student marketplace; Opinit, an app that enables users to socially share their favourite online sentiment-driven content; and Truth, a one-to-one anonymous messaging app.
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles on the SEDAR website (www.sedar.com) and on the Canadian Securities Exchange’s website (www.thecse.com).
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone:  514-561-9091
Email: bmoore@cannappscorp.com
For more information, please contact:
Corporate Communications
Telephone: 1.855.269.9554
Email: info@cannappscorp.com
www.cannappscorp.com
Forward-Looking Information
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC.  Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC.  Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct.  Forward-looking statements contained in this press release are made as of the date of this press release.  GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Click here to connect with Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF)) to receive an Investor Kit.

Source: www.stockhouse.com


Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less